Re: [爆卦] 中国通过BNT审查,预计做为第三针补充剂

楼主: A6 (短ID真好)   2021-07-15 21:11:51
※ 引述《gibbs1286 (学无止境是国关)》之铭言:
: https://reurl.cc/4a88LV
: 路透社报导
: Fosun-BioNTech COVID-19 vaccine completes China regulator review - media
: SHANGHAI, July 15 (Reuters) - Chinese regulators have completed an expert
: review of a COVID-19 mRNA vaccine developed by Germany's BioNTech (22UAy.DE)
: and Fosun Pharma (600196.SS) and the shot is in the administration review
: stage, Caixin reported, citing the Chinese company.
那这不就 糟糕了
之前不诚实中才说 中国在打得我们不敢用耶
现在大陆要打BNT了
这样台湾是不是要 BNT NO
国内疫苗用量吃紧,近日地方政府纷纷祭出自救措施,中国大陆国台办也提出,上海复星
医药集团有意愿将其代理的德国BNT疫苗给予台湾民众。对此,中央流行疫情指挥官陈时
中今天透露,疫苗是救命的,是有它的风险在,审查上面也要很严谨,“他们(中国)没
在打的我们有点兴趣,他们在打的,我们不敢用。”
CDC也要转弯惹ㄇ
嘻嘻
: China hasn't approved any COVID-19 vaccine developed overseas but
: greenlighted several domestic brands, administering 1.4 billion doses so far,
: or two-fifths of the global total of 3.47 billion doses.
: BioNTech Chief Executive Ugur Sahin said in April he expected its COVID-19
: vaccine would win approval from the Chinese authorities "by June at the
: latest."
: BioNTech and Fosun did not immediately reply to Reuters' requests for comment.
: The vaccine is on track to begin trial production in China at the end of
: August, Caixin cited Fosun Pharma chairman Wu Yifang as saying at a
: shareholders' meeting on Wednesday.
: It said the vaccine would be used as a booster shot for people who have
: received vaccines using inactivated viruses.
: These are vaccines that use a coronavirus that cannot replicate in human
: cells and include Sinovac's (SVA.O) COVID-19 shot.
: 简单来说就是中国政府对BNT疫苗已经通过专家审查,进入行政审查并预计作为那些打过
: 科兴、国药的人的第三针加强剂,然后八月底复星在中国开始试生产BNT疫苗
: 复星:反正你最后都还是要打BNT的,为什么不一开始就打BNT呢,ㄏㄏ
: 好险郭董跟GG已经完成签约了,不然再过几个月复星真的可能不卖台湾了....因为优先供给中国国内
: 只是这算是侧面说中国国产疫苗算是不成功吗?因为最后还是要打国外的疫苗XD

Links booklink

Contact Us: admin [ a t ] ucptt.com